Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
RPE mitochondrial deficits and complement C3a receptor activation drive retinal degeneration in frontotemporal dementia.
Author Affiliations & Notes
  • an cheng
    Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Li Xuan Tan
    Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Aparna Lakkaraju
    Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Footnotes
    Commercial Relationships   an cheng None; Li Xuan Tan None; Aparna Lakkaraju None
  • Footnotes
    Support  NIH grant R01EY030668; The Bright Focus Foundation Lorraine Maresca award for Innovative research in AMD M2021020I
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2558. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      an cheng, Li Xuan Tan, Aparna Lakkaraju; RPE mitochondrial deficits and complement C3a receptor activation drive retinal degeneration in frontotemporal dementia.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2558.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Frontotemporal dementia (FTD) is the most common cause of cognitive deficits in people under the age of 65. Mutations in the GRN gene, which codes for progranulin, are implicated in FTD (GRN-FTD). Progranulin is a multifunctional protein that is thought to regulate lysosome function, inflammation, and neuronal health. Retinal deficits have been reported in GRN-FTD patients and Grn-/- mice. Despite these observations, precisely how the absence of progranulin results in retinal neurodegeneration remains unclear. Here, we identify novel mechanisms underlying retinal neurodegeneration in GRN-FTD and propose potential therapeutic approaches.

Methods : Grn-/- mice were used to investigate the mechanisms by which progranulin loss causes retinal degeneration. Mouse RPE flatmounts, paraffin sections, RPE lysates were used for immunofluorescence imaging, retinal thickness measurements, and immunoblotting respectively. For a precise evaluation of mitochondrial dynamics, high-speed, high-resolution live imaging using spinning disc confocal microscopy was employed. RNA-seq analysis of RPE from 4 and 14-month-old mice was performed to identify novel pathways triggered by progranulin loss and validate our imaging data.

Results : Paraffin sections and cryo-section staining showed a reduction in thickness of the outer nuclear layer (ONL) in 12- and 17-month-old Grn-/- mice compared to controls. Surprisingly, analysis of 4- and 14-month-old Grn-/- mice showed that clearance of phagocytosed photoreceptor outer segments proceeded normally, suggesting normal lysosome function. However, live imaging of mitochondrial dynamics in 4-month-old mouse RPE flatmounts revealed hyperfused mitochondria defective in ATP production. These hyperfused mitochondria activate NFkB, leading to increased secretion of the biologically active complement C3 fragment, C3a. This in turn activates C3aR on microglia subsequently triggering microglia migration and activation. Supporting this, RNA-sequence analyses of Grn-/- mice RPE reveal an upregulation of complement and inflammatory cascade signaling.

Conclusions : Our data show that RPE mitochondrial deficits are an early pathological trigger in in Grn-/- mice. This activates C3aR signaling on maladaptive microglia, leading to photoreceptor degeneration. C3aR represents a potential target for GRN-FTD therapy.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×